These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11465919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG.
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [Abstract] [Full Text] [Related]

  • 11. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L, Dib M, Doppler V, Faudet A, Robin V, Salachas F, Bensimon G, Meininger V.
    Therapie; 2002 Feb; 57(1):65-71. PubMed ID: 12090150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Do the benefits of currently available treatments justify early diagnosis and announcement? Arguments for.
    Cashman NR.
    Neurology; 1999 Feb; 53(8 Suppl 5):S50-2; discussion S55-7. PubMed ID: 10560639
    [Abstract] [Full Text] [Related]

  • 14. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M.
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG.
    Amyotroph Lateral Scler; 2010 May 03; 11(3):259-65. PubMed ID: 19961263
    [Abstract] [Full Text] [Related]

  • 18. The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS).
    Vardeny O, Bromberg MB.
    J Herb Pharmacother; 2005 May 03; 5(3):23-31. PubMed ID: 16520295
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Etiological drug therapy for amyotrophic lateral sclerosis].
    Cintas P.
    Rev Neurol (Paris); 2006 Jun 03; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.